UBS AM’s Tecogen Inc TGEN Stock Holding History

UBS AM’s Portfolio TGEN Stock Details TGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.26K	Hold	1,583	–	–	﹤0.01%	3315
2026 Q1	$4.05K	Buy	+1,583	New	+$5.82K	﹤0.01%	3494

Other funds holding TGEN

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

CHAM

Clear Harbor Asset Management Stamford, Connecticut $1.62B AUM 38.77% 1-Year Est. Return

HIM

Herald Investment Management London, United Kingdom $737M AUM 158.15% 1-Year Est. Return

Gratia Capital Los Angeles, California $165M AUM 34.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MIM

Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return

PIP

Palisades Investment Partners Santa Monica, California $352M AUM 76.79% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS AM's TGEN Position: Q2 2026 in Review

UBS AM held its Tecogen Inc (TGEN) position steady in Q2 2026 at 1,583 shares worth $8.26K. The position accounts for ﹤0.01% of the portfolio, ranked #3315.

UBS AM first reported a position in TGEN in Q1 2026 and has held it in 2 quarters since. 69 funds tracked by Wall St. Rank hold TGEN as of Q2 2026.

UBS AM held 1,583 shares of Tecogen Inc worth $8.26K as of Q2 2026.
UBS AM left its Tecogen Inc share count unchanged in Q2 2026.
Tecogen Inc made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3315 holding.
UBS AM first reported a position in Tecogen Inc in Q1 2026 and has held it in 2 quarters since.
69 funds tracked by Wall St. Rank held Tecogen Inc as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.